Consistent with the above results, overexpression of TRIM59 markedly accelerated the degradation of endogenous IRF6 in neuroblastoma cells after treatment with CHX, indicating that TRIM59 could shorten the half-life of the IRF6 protein (Fig. 5J). Here, IRF6 is linked to neuroblastoma.